Literature DB >> 3585572

Women's and physicians' utilities for health outcomes in estrogen replacement therapy.

M M Holmes, D R Rovner, M L Rothert, A S Elstein, G B Holzman, R B Hoppe, W P Metheny, M M Ravitch.   

Abstract

Estrogen replacement therapy (ERT) prevents fractures and relieves vasomotor symptoms, but it increases the risk of endometrial cancer. Previous studies and national prescribing patterns show that physicians are conservative in their approach to this therapy. The authors interviewed physicians and perimenopausal women to assess their utilities for the various health outcomes of estrogen replacement therapy. On all outcomes, physicians rated illness episodes followed by recovery as being closer to perfect health than did perimenopausal women. Physicians, in judging which outcomes were most important to women, estimated relief of symptoms above fracture prevention, whereas women rated fracture prevention above symptom relief. These results emphasize the need to assess patients' utilities directly, particularly when utilities for the outcome of a particular therapy may influence the choice of a therapeutic regimen.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3585572     DOI: 10.1007/bf02596148

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  11 in total

1.  Cancer statistics. 1986.

Authors:  E Silverberg
Journal:  CA Cancer J Clin       Date:  1986 Jan-Feb       Impact factor: 508.702

2.  Comparison of physicians' decisions regarding estrogen replacement therapy for menopausal women and decisions derived from a decision analytic model.

Authors:  A S Elstein; G B Holzman; M M Ravitch; W A Metheny; M M Holmes; R B Hoppe; M L Rothert; D R Rovner
Journal:  Am J Med       Date:  1986-02       Impact factor: 4.965

Review 3.  Epidemiology of osteoporosis and osteoporotic fractures.

Authors:  S R Cummings; J L Kelsey; M C Nevitt; K J O'Dowd
Journal:  Epidemiol Rev       Date:  1985       Impact factor: 6.222

4.  Decision analysis: introductory lectures on choices under uncertainty. 1968.

Authors:  H Raiffa
Journal:  MD Comput       Date:  1993 Sep-Oct

5.  Physicians' judgments about estrogen replacement therapy for menopausal women.

Authors:  G B Holzman; M M Ravitch; W Metheny; M L Rothert; M Holmes; R B Hoppe
Journal:  Obstet Gynecol       Date:  1984-03       Impact factor: 7.661

6.  Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program Follow-Up Study.

Authors:  T L Bush; L D Cowan; E Barrett-Connor; M H Criqui; J M Karon; R B Wallace; H A Tyroler; B M Rifkind
Journal:  JAMA       Date:  1983-02-18       Impact factor: 56.272

7.  On the elicitation of preferences for alternative therapies.

Authors:  B J McNeil; S G Pauker; H C Sox; A Tversky
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

8.  Noncontraceptive estrogens and progestins: use patterns over time.

Authors:  D L Kennedy; C Baum; M B Forbes
Journal:  Obstet Gynecol       Date:  1985-03       Impact factor: 7.661

9.  Assessment of patients' preferences for therapeutic outcomes.

Authors:  S A Eraker; H C Sox
Journal:  Med Decis Making       Date:  1981       Impact factor: 2.583

10.  Cost-effectiveness of hormone replacement therapy in the menopause.

Authors:  M C Weinstein; I Schiff
Journal:  Obstet Gynecol Surv       Date:  1983-08       Impact factor: 2.347

View more
  6 in total

1.  Subjectivity in decision making: common problems and limitations.

Authors:  M M Ravitch
Journal:  World J Surg       Date:  1989 May-Jun       Impact factor: 3.352

2.  A multi-attribute model of prostate cancer patient's preferences for health states.

Authors:  G B Chapman; A S Elstein; T M Kuzel; R B Nadler; R Sharifi; C L Bennett
Journal:  Qual Life Res       Date:  1999-05       Impact factor: 4.147

3.  Effects of a physician communication intervention on patient care outcomes.

Authors:  S K Joos; D H Hickam; G H Gordon; L H Baker
Journal:  J Gen Intern Med       Date:  1996-03       Impact factor: 5.128

4.  Cholesterol-lowering therapy: what patients expect in return.

Authors:  W W Reed; J E Herbers; G L Noel
Journal:  J Gen Intern Med       Date:  1993-11       Impact factor: 5.128

5.  Ethnic differences in hormone replacement prescribing patterns.

Authors:  A F Brown; E J Pérez-Stable; E E Whitaker; S F Posner; M Alexander; J Gathe; A E Washington
Journal:  J Gen Intern Med       Date:  1999-11       Impact factor: 5.128

6.  Hormone therapy after the Women's Health Initiative: a qualitative study.

Authors:  Linda M French; Mindy A Smith; Jodi S Holtrop; Margaret Holmes-Rovner
Journal:  BMC Fam Pract       Date:  2006-10-23       Impact factor: 2.497

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.